Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by BurningFrog on Friday June 11, 2021 @11:17AM (#27474524)

There is inconclusive evidence that it works.

That's in theory a good scenario for allowing some level of use.

If this practical level of use is good, I don't know.

[ Parent | on HN ]

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by paulpauper on Friday June 11, 2021 @01:39PM (#27476288)

Given the costs, I don't think this is good enough. Medicare cannot afford to subsidize things are inconclusive especially given how 6 million Americans have Alzheiemrs.

[ Parent | on HN ]

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by BurningFrog on Friday June 11, 2021 @06:42PM (#27479407)

I think a sane system would be where a drug is legal to use, and Medicare can decide it's not worth paying for.

Those should be be independent decisions.

[ Parent | on HN ]

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by mcguire on Friday June 11, 2021 @02:27PM (#27476876)

The $50k/year above times 6 million is $300B. For $300,000,000,000, I suspect no one cares whether it works.

[ Parent | on HN ]

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by CincinnatiMan on Friday June 11, 2021 @03:17PM (#27477354)

What do you mean by this? That sounds like a lot of money and I would think taxpayers would care if such a large amount were to be essentially thrown away.

[ Parent | on HN ]